(Q81660032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Xiao-Yan Qiu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ming Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Long-Jin Zhong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Hui-Qi Liang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Chun-Lai Ma

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Liang Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ming-Kang Zhong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

18 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1069-1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18636247%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-008-0520-8

10 January 2020

exact match

0 references

cites work

Influence of CYP3A5 genetic polymorphism on cyclosporine A metabolism and elimination in Chinese renal transplant recipients

1 reference

12 December 2020

Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene

1 reference

12 December 2020

The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients

1 reference

12 December 2020

Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.

1 reference

12 December 2020

Molecular and physical mechanisms of first-pass extraction

1 reference

12 December 2020

Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.

1 reference

12 December 2020

Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients

1 reference

12 December 2020

No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients

1 reference

12 December 2020

Patient management by Neoral C(2) monitoring: an international consensus statement

1 reference

12 December 2020

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

1 reference

12 December 2020

Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population.

1 reference

12 December 2020

MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients.

1 reference

12 December 2020

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients

1 reference

12 December 2020

Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus

1 reference

12 December 2020

The use of cyclosporine in renal transplantation

1 reference

12 December 2020

Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups

1 reference

12 December 2020

The role of individual human cytochromes P450 in drug metabolism and clinical response

1 reference

12 December 2020

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

1 reference

12 December 2020

Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations

1 reference

12 December 2020

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

1 reference

12 December 2020

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

1 reference

12 December 2020

MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.

1 reference

12 December 2020

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

1 reference

12 December 2020

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

12 December 2020

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

1 reference

12 December 2020

The clinical benefits of cyclosporine C2-level monitoring: a systematic review

1 reference

12 December 2020

[Effect of MDR1 polymorphic expression on oral disposition of cyclosporine A].

1 reference

12 December 2020

Identification of functionally variant MDR1 alleles among European Americans and African Americans

1 reference

12 December 2020

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

12 December 2020

Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene

1 reference

12 December 2020

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

1 reference

12 December 2020

Relationship between MDR1 polymorphism and blood concentration of cyclosporine A

1 reference

12 December 2020

Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements

1 reference

12 December 2020

MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.

1 reference

12 December 2020

Switching cyclosporine blood concentration monitoring from C0 to C2 in children late after liver transplantation

1 reference

12 December 2020

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

1 reference

12 December 2020

Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects

1 reference

12 December 2020

Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients

1 reference

12 December 2020

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

1 reference

12 December 2020